Maine Medicine Weekly Update
October 18, 2021

In This Issue
FDA Advisory Committee Recommends Moderna, J&J Boosters. What You Need to Know
More COVID Guidance & News
Maine CDC Memos: Planning Efforts for Moderna Booster and Pfizer Vaccine for 5-11-year-olds
Draft Study Shows Moderna & Pfizer May Be Better Boost for J&J Recipients
FDA Schedules Advisory Committee Meeting to Discuss COVID-19 Oral Treatment
Federal COVID Vaccine Mandate Rules Have Been Drafted
Maine Health System News
Central Maine Healthcare Services, Staffing, Vaccine Mandate, CEO Appointment
Clinical News
New Draft Recommendation Statement on Aspirin Use to Prevent Heart Disease and Stroke
Top JAMA, JAMA Network, and New England Journal of Medicine Articles
Physician Well Being
Using Electronic Health Records to Predict Physician Departure
Preventing Stimulant Misuse Among College-Aged Students
Upcoming Specialty Society Meetings
AAP EQIPP Course: Immunizations - Strategies for Success (for RURAL Health Providers)
SUPPORT for ME Training and Technical Assistance Initiative
SUPPORT For ME Training and Technical Assistance Initiative Webinars on November 3 & December 1
Maine Independent Clinical Information Service: MICIS presentations & Academic Detailing
Physician (BC/BE in Family Medicine) - Mt. Abram Regional Health Center, (Kingfield, Maine)
Physician (BC/BE in Family Medicine) - Bingham Area Health Center

Search Back Issues




Follow Us:
Draft Study Shows Moderna & Pfizer May Be Better Boost for J&J Recipients

A new National Institutes of Health (NIH) study suggested Moderna's or Pfizer's vaccine also work as a booster for J&J recipients and may benefit more from getting a Pfizer or Moderna vaccine as their booster instead of another J&J shot. The study is preliminary and hasn't been peer reviewed.

People who received an mRNA-based booster vaccination had a four-fold increase in their neutralization response more frequently than those who were boosted with J&J's adenovirus vaccine.

During the Friday meeting of the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC), a top FDA official told the committee that the agency might consider allowing Johnson & Johnson recipients to receive a booster shot of the Moderna or Pfizer-BioNTech vaccines but gave no timetable for that decision.

Click here for NPR story on NIH study: NIH study of COVID-19 vaccine boosters suggests Moderna or Pfizer works best

Click here for a draft of the NIH study: Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report

< Previous Article | Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm

Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©